Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | TNKS | O95271 | 1/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.46 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28433698 | 1.00 | LMNA (0.50) | LMNAALDH1A1AKR1B10AKR1B1TDP1 | |
| SCHEMBL30472929 | 0.84 | LMNA (0.63) | LMNATDP1KMT2AMAPTHDAC3 | |
| SCHEMBL28197285 | 0.84 | ALDH1A1 (0.47) | LMNAALDH1A1AKR1B10AKR1B1TDP1 | |
| SCHEMBL27732203 | 0.83 | LMNA (0.56) | LMNAALDH1A1AKR1B10AKR1B1TDP1 | |
| SCHEMBL27732204 | 0.83 | LMNA (0.56) | LMNAALDH1A1AKR1B10AKR1B1TDP1 | |
| SCHEMBL15569161 | 0.82 | LMNA (0.51) | LMNAALDH1A1AKR1B10AKR1B1TDP1 | |
| SCHEMBL11317021 | 0.82 | LMNA (0.57) | LMNAALDH1A1AKR1B10AKR1B1TDP1 | |
| SCHEMBL9116949 | 0.82 | LMNA (0.57) | LMNAALDH1A1AKR1B10AKR1B1TDP1 | |
| SCHEMBL29010570 | 0.79 | LMNA (0.51) | LMNAALDH1A1AKR1B10AKR1B1TDP1 | |
| SCHEMBL28160312 | 0.79 | GLA (0.53) | LMNAALDH1A1AKR1B10AKR1B1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111363415-A | Slow-odor type high-strength nano composite colored lead core and preparation method thereof | 烟台好前程文具有限公司 | 2020-07-03 | — | — | CN | claimed |
| WO-2010105922-A1 | IMPROVEMENTS RELATING TO BENEFIT AGENT DELIVERY | UNILEVER PLC (GB) | 2010-09-23 | — | — | WO | claimed |
| EP-1567629-B1 | LAUNDRY TREATMENT COMPOSITIONS AND COMPONENTS THEREFOR | UNILEVER PLC (GB) | 2007-03-07 | — | — | EP | claimed |
| CN-111363415-A | Slow-odor type high-strength nano composite colored lead core and preparation method thereof | 烟台好前程文具有限公司 | 2020-07-03 | — | — | CN | disclosed |
| CN-106604715-B | Use of benefit delivery particles for off-flavour benefits | 荷兰联合利华有限公司 | 2020-04-17 | — | — | CN | disclosed |
| CN-110461419-A | It is provided with the cosmetic preparation of mesh | CHANEL PARFUMS BEAUTE | 2019-11-15 | — | — | CN | disclosed |
| EP-2911643-B1 | IMPROVEMENTS RELATING TO ENCAPSULATED BENEFIT AGENTS | UNILEVER PLC (GB) | 2018-12-05 | — | — | EP | disclosed |
| US-10117815-B2 | Improvements relating to encapsulated benefit agents | CONOPCO, INC. (US) | 2018-11-06 | — | — | US | disclosed |
| US-10034818-B2 | Use of a benefit delivery particle for malodour benefit | CONOPCO, INC. (US) | 2018-07-31 | — | — | US | disclosed |
| EP-3148650-B1 | BENEFIT DELIVERY PARTICLE FOR TREATING SUBSTRATES | UNILEVER PLC (GB) | 2018-07-04 | — | — | EP | disclosed |
| US-9993401-B2 | Benefit delivery particle, process for preparing said particle, compositions comprising said particles and a method for treating substrates | CONOPCO, INC. (US) | 2018-06-12 | — | — | US | disclosed |
| US-20030068495-A1 | Treatment for substrates | UNILEVER HOME & PERSONAL CARE USA | 2003-04-10 | — | — | US | disclosed |
| WO-2003020770-A1 | POLYMERS AND THEIR USE | UNILEVER PLC (GB) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003020819-A1 | LAUNDRY TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2003-03-13 | — | — | WO | disclosed |
| WO-2003014278-A1 | TREATMENT FOR SUBSTRATES | UNILEVER PLC (GB) | 2003-02-20 | — | — | WO | disclosed |
| WO-2003010206-A1 | POLYMERS AND THEIR SYNTHESIS | UNILEVER PLC (GB) | 2003-02-06 | — | — | WO | disclosed |
| WO-2003010268-A1 | USE OF COMPOUNDS IN PRODUCTS FOR LAUNDRY APPLICATIONS | UNILEVER PLC (GB) | 2003-02-06 | — | — | WO | disclosed |
| WO-2003010267-A1 | USE OF POLYMERS IN FABRICS CLEANING | UNILEVER PLC (GB) | 2003-02-06 | — | — | WO | disclosed |
| EP-1117755-A1 | TREATMENT FOR SUBSTRATES | UNILEVER PLC (GB) | 2001-07-25 | — | — | EP | disclosed |
| WO-2000018861-A1 | TREATMENT FOR SUBSTRATES | UNILEVER PLC (GB) | 2000-04-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10117815-B2 | Improvements relating to encapsulated benefit agents | CD44, HSPA2, HSPA1A | LMNA 821/4885ALDH1A1 238/4885AKR1B10 1813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.